Company: IXHL
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001213900-25-013783
Chunk: 218

Company: Incannex Healthcare Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part II, Item 2
Chunk 218
---
 to the SEC upon request.

26

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    Incannex Healthcare Inc.

    Date: February 14, 2025
    By:
    /s/ Joel Latham

    Joel Latham

    Chief Executive Officer, 
Director and President

    Date: February 14, 2025
    By:
    /s/ Joseph Swan

    Joseph Swan

    Chief Financial Officer, 
Treasurer and Secretary

27

0001873875
false
2025
Q2
--06-30

    0001873875

    2024-07-01
    2024-12-31

    0001873875

    2025-02-14

    0001873875

    2024-12-31

    0001873875

    2024-06-30

    0001873875

    2024-10-01
    2024-12-31

    0001873875

    2023-10-01
    2023-12-31

    0001873875

    2023-07-01
    2023-12-31

    0001873875
    
      us-gaap:CommonStockMember

    2024-06-30

    0001873875
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-06-30

    0001873875
    
      us-gaap:RetainedEarningsMember

    2024-06-30

    0001873875
    
      us-gaap:AccumulatedTranslationAdjustmentMember

    2024-06-30

    0001873875
    
      us-gaap:CommonStockMember

    2024-07-01
    2024-12-31

    0001873875
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-07-01
    2024-12-31

    0001873875
    
      us-gaap:RetainedEarningsMember

    2024-07-